Chiral separation of Tamsulosin isomers by HPLC using cellulose Tris (3,5-dimethhylphenylcarbamate) as a chiral stationary phase

Journal of Pharmaceutical and Biomedical Analysis

Volumn 34, Issue 3, 2004, Pages 689-693

  Zhang, Zhefeng ^a   Yang, Gengliang ^a,c   Liang, Guijian ^b   Liu, Haiyan ^a   Chen, Yi ^c  

^a HEBEI UNIVERSITY   (China)

^b AIR FORCE GENERAL HOSPITAL   (China)

^c INSTITUTE OF CHEMISTRY   (China)

Author keywords

Cellulose tris (3, 5 dimethylphenylcarbamate) stationary phase; Chiral separation; Isomer; Tamsulosin (5 (2R) 2 l amino propyl 2 methoxy benzenesulfonamide)

Indexed keywords

ACETONITRILE; ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 1A ADRENERGIC RECEPTOR; CELLULOSE TRIS(3,5 DIMETHYLPHENYLCARBAMATE); TAMSULOSIN;

ARTICLE; CALIBRATION; CHIRALITY; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOMER; PH MEASUREMENT; PRIORITY JOURNAL;

EID: 0842281550     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(03)00555-7     Document Type: Article

References (15)

1. A. Goodman-Gilman, L.S. Goodman, W. Rall, F. Murad (Eds.), The Pharmacological Basis of Therapeutics, McMillen Publishing Co., New York, NY, 1985.
2. FDA Policy Statement for the Development of New Stereoisomeric Drugs, Washington, DC, May 1992.
3. Yang G., Li Z., Wang D., Zhang E., Chen Y. Chromatographia. 56:2002;515-518.
4. Yang G., Liu H., Li H., Wang Y., Chen Y. Chromatographia. 57:2003;245-248.
5. Zavitsanos A.P., Alebic-Kolbah T. J. Chromatogr A. 794:1998;45-56.
6. Gasparrini F., Misiti D., Villani C. J. Chromatogr A. 906:2001;35-50.
7. Yashima E. J. Chromatogr A. 906:2001;105-125.
8. Herráez-Hernández R., Camp P. Anal. Chimi Acta. 434:2001;315-324.
9. Chankvetadze B., Burjanadze N., Blaschke G. J. Pharm. Biomed. Anal. 27:2002;153-159.
10. Gilar M., Uhrova M., Tesarova E. J. Chromatogr. B. 681:1996;133-141.
11. Pharmaceutical Information Associates, Ltd. (PIA), Medical Sciences Bulletin, September 1997, p. 240.
12. Narayan P., Tewari A. J. Urol. 160:1998;1701-1706.
13. Lepor H. Tamsulosin Invest. Group Urol. 51:1998;892-900.
14. Tkachuk V., AlShakri S., Kuznetsova M.et al. Urol. Nefrol. 5:2000;18-20.
15. Chapple C., Andersson K.-E. World J. Urol. 19:2002;397-404.